Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
357 Leser
Artikel bewerten:
(2)

King Street Capital Management: King Street and Freo Group Sell a 38,000 Sqm Office Campus in Barcelona

Finanznachrichten News

LONDON, Aug. 10, 2022 /PRNewswire/ -- King Street Capital Management ("King Street"), a leading global alternative investment firm, and Freo Group ("Freo"), a leading international investment and asset manager, have successfully agreed to sell through a forward sale agreement a new LEED Platinum office complex in Barcelona, Spain.

King Street Capital Management

The 38,000 sqm asset, composed of three buildings, is located in the heart of the 22@ business district, an established sub-market attracting prime tenants looking for modern grade A offices. Large international technology firms have a strong presence in the area, which continues to appeal to a younger, affluent talent pool. The buildings, which are currently under construction, are targeting to be delivered between Q4 2022 and Q1 2023.

As a LEED Platinum certified development, MILE22@ has 57% of water consumption savings and 36% of energy savings, and was designed with rooftop solar panels and sustainable construction materials that are 23% recycled. In addition, its communal gardens, private terraces and views of Barcelona and the Mediterranean Sea are all factors that continue to attract tenants such as large international technology firms, as well as high-caliber talent.

Paul Brennan, Managing Director and Head of European Real Estate at King Street, said: "The sale of this asset underscores King Street's ability to successfully execute on our build-to-core strategy of developing and leasing sustainable, next-generation workplaces in major European cities"

Oscar de Navas, Managing Director, Freo Group, said: "After four years of active asset management, going through permitting, construction and leasing, we're really proud to close this successful transaction. 22@ District has been a key submarket for Freo and will continue to be in the future."

King Street has committed over $4 billion of equity across 60 private real estate transactions since 2010. King Street has been investing in real estate in Spain since 2012. To date, King Street has directly and indirectly invested more than $1 billion of equity into real estate in Spain.

Freo Group has invested over €1 billion in the Spanish real estate market since 2015 and is willing to continue growing in the coming years.

King Street and Freo Group were advised by CBRE, Savills, Uria Menendez and Deloitte

About King Street Capital Management

King Street is a global alternatives investment firm founded in 1995 that manages approximately $22 billion in assets across public and private markets. The firm marries rigorous fundamental research with tactical trading and differentiated sourcing capabilities to identify misunderstood and complex investment opportunities across asset classes, up and down the capital structure. For more information, please visit www.kingstreet.com.

About Freo Group

Freo is an international real estate investment, development and asset management group established in 1996. With approximately €2 billion of assets under management, Freo is internationally present with offices in Germany, France, UK, Spain and other selected markets in Central and Western Europe. The company employs a team of over 80 highly qualified real estate and finance professionals, experienced in the areas of asset management and leasing, development, debt, equity and transaction structuring and fund management.

Media Contacts

Prosek Partners for King Street
pro-kingstreet@prosek.com

Logo - https://mma.prnewswire.com/media/1834844/King_Street_Logo.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.